Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study

Atherosclerosis

Volumn 217, Issue 2, 2011, Pages 503-508

  Ku, Ivy A ^a,b   Farzaneh Far, Ramin ^a,b   Vittinghoff, Eric ^b   Zhang, Mary H ^d   Na, Beeya ^c   Whooley, Mary A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adipokine; Coronary artery disease (CAD); Leptin; Reverse epidemiology

Indexed keywords

LEPTIN;

AGE; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RACE; SEX; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DOWN-REGULATION; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; LEPTIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO; STROKE;

EID: 79960700893     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.10.047     Document Type: Article

References (27)

1. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
2. Yang R., Barouch L.A. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007, 101:545-559.
3. Bouloumie A., Marumo T., Lafontan M., Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J 1999, 13:1231-1238.
4. Lembo G., Vecchione C., Fratta L., et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000, 49:293-297.
5. Bodary P.F., Westrick R.J., Wickenheiser K.J., Shen Y., Eitzman D.T. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 2002, 287:1706-1709.
6. Smith C.C., Mocanu M.M., Davidson S.M., et al. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 2006, 149:5-13.
7. Sattar N., Wannamethee G., Sarwar N., et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 2009, 53:167-175.
8. Söderberg S., Ahrén B., Jansson J.H., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999, 246:409-418.
9. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104:3052-3056.
10. Wallerstedt S.M., Eriksson A.L., Niklason A., Ohlsson C., Hedner T. Serum leptin and myocardial infarction in hypertension. Blood Press 2004, 13:243-246.
11. Brennan A.M., Li T.Y., Kelesidis I., et al. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 2007, 50:1178-1185.
12. Couillard C., Lamarche B., Mauriège P., et al. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998, 21:782-786.
13. Lawlor D.A., Smith G.D., Kelly A., Sattar N., Ebrahim S. Leptin and coronary heart disease risk: prospective case control study of British women. Obesity (Silver Spring) 2007, 15:1694-1701.
14. Karakas M., Zierer A., Herder C., et al. Leptin, adiponectin, their ratio and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984-2002. Atherosclerosis 2010, 209:220-225.
15. Piemonti L., Calori G., Mercalli A., et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003, 26:2883-2889.
16. Scholze A., Rattensperger D., Zidek W., Tepel M. Low serum leptin predicts mortality in patients with chronic kidney disease stage 5. Obesity (Silver Spring) 2007, 15:1617-1622.
17. Wolk R., Berger P., Lennon R.J., et al. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004, 44:1819-1824.
18. Whooley M.A., de Jonge P., Vittinghoff E., et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300:2379-2388.
19. Ruo B., Rumsfeld J.S., Hlatky M.A., et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 2003, 290:215-221.
20. Luepker R.V., Apple F.S., Christenson R.H., et al. Circulation 2003, 108:2543-2549.
21. Rathmann W., Herder C. Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology" Horm Metab Res 2007, 39:1-2.
22. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009, 53:1925-1932.
23. Wolk R., Deb A., Caplice N.M., Somers V.K. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis 2005, 183:131-139.
24. Vecchione C., Maffei A., Colella S., et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002, 51:168-173.
25. Kelesidis T., Kelesidis I., Chou S., Mantzoros C.S. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 2010, 152:93-100.
26. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009, 297:E1247-E1259.
27. Janik J.E., Curti B.D., Considine R.V., et al. Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997, 82:3084-3086.